ID NOW™: A Reliable, Rapid, and Point-of-Care Molecular COVID-19 Test
The ID NOW™ COVID-19 by Abbott is transforming SARS-CoV-2 screening with its isothermal molecular technology, delivering reliable results in 13 minutes or less. Unlike antigen tests, this method directly detects the viral genetic material, providing enhanced sensitivity that is crucial for early and accurate detection.
This device is specifically designed for near-patient settings such as medical practices, clinics, mobile testing units, and hospital facilities. Its intuitive interface and compact design make it an ideal solution for quick and autonomous use by healthcare professionals, without the need for extensive technical training.
One of the key advantages of the ID NOW™ system is its ability to deliver molecular diagnostic results on-site during the patient's initial visit. This eliminates delays associated with laboratory testing and enables immediate implementation of care and infection control measures, improving patient management and public health response.
The test can be performed using various sample types—nasal, throat, or nasopharyngeal swabs—offering flexibility to meet different clinical needs. The kit includes all necessary collection swabs as well as a positive control to ensure result reliability.
Another notable feature is that all components can be stored at room temperature, significantly simplifying logistics—particularly for mobile settings or areas with limited access to refrigeration.
With the ID NOW™ COVID-19 test, Abbott delivers a powerful, proven tool for fast, accurate, and efficient SARS-CoV-2 detection, making it a leading reference in point-of-care molecular diagnostics.
